SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending as the community eagerly anticipates the multi-billion dollar NASA Lunar Terrain Vehicle (LTV) contract award and upcoming earnings, following its recent $175 million strategic equity investment and the integration of its Lanteris acquisition. High short interest and broader enthusiasm for the "moon economy" are fueling significant volatility and debate around the stock's future in space infrastructure.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as the market anticipates its pivotal Q4 earnings report, with sentiment sharply divided between expectations of a blowout performance driving new highs and concerns over a potential "sell the news" event. Discussions are also active around the future of AI demand, competition, and the upcoming Rubin AI system.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is trending following its strong earnings report, showcasing surging stablecoin demand and USDC circulation growth, igniting community debate around a potential short squeeze and its foundational role in digital finance, while others remain cautious given valuation concerns and ongoing regulatory hurdles.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending due to highly polarized reactions to Donald Trump's recent State of the Union address, where community discussion is intensely divided over his political rhetoric, economic claims, and controversy surrounding the Epstein files; this has investors and commentators sharply split between those celebrating the speech as a success that will drive the stock and those criticizing it as a "lie-a-thon" underscoring the company's speculative fundamentals.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind Corp is trending due to anticipation surrounding its upcoming Q4 earnings and business update, with positive sentiment driven by partner United Therapeutics' strong Tyvaso DPI sales and the potential for Afrezza's pediatric FDA approval. The community is actively discussing future catalysts, including upcoming Teton-1 study results and the implications of competing inhaler technologies.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following recent announcements of an innovation hub in India and a new "Sales Assist" agent, all ahead of its highly anticipated earnings report. Community discussion is focused on strong expectations for revenue growth and a path to profitability, with high short interest fueling speculation of a potential squeeze for its patented voice AI technology across automotive, QSR, and enterprise sectors.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending following its earnings report, which highlighted its consistent "beat and raise" streak and AI-powered marketing platform's strong performance, sparking community discussion about its undervalued position despite ongoing software sector sell-offs.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech is trending after projecting a significant revenue decline for its upcoming quarter, sparking a sharp sell-off and contrasting with its history of strong financial performance. The community is actively debating if the market reaction is an overcorrection and a buying opportunity, given the company's share buyback program, or if the stock faces further downside amidst an undefined bottom.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is trending after its 2026 sales guidance fell below consensus, prompting analyst downgrades and a stock decline. The community is actively debating if this creates a buying opportunity, weighing the near-term outlook against the company's strong US manufacturing position and potential tailwinds from AI data center energy demand.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending down sharply after its latest earnings report, despite beating EPS and revenue estimates, as cautious fiscal year 2027 revenue guidance amplifies broader market concerns about AI's disruptive impact on the software sector. The community is actively debating if the current sell-off is an overreaction to strong underlying fundamentals or a justified repricing given the evolving landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$XERS I don’t think that she will go up much higher after the 4th qr earning report on 3-2, but it could dive if the CEO delivers slow revenue growth or weak revenue guidance. I wouldn’t be surprised to see $5 or even $4 on the earning date. What XERS really needs is that we need a new CEO and management team who can aggressively turn things around 🥲🥲

John Redcorn

Scooter

Fred Garcia

$XERS I think XERS has a GREAT Management team that has Delivered.  But then some people have a short attention span and are never satisfied.  Check the chart below.  The stock has trippled in the last 1.5 years at the current price.  Note that the management&#39;s job is to grow the Business NOT to keep tabs on the daily stock price.  When mangement takes care of and grows the business, the stock price will take care of itself.  We have GREAT Management!!!

StockTwits Web

Simon C

Xeris Biopharma Holdings Inc

 I don’t think that she will go up much higher after the 4th qr earning report on 3-2, but it could dive if the CEO delivers slow revenue growth or weak revenue guidance. I wouldn’t be surprised to see $5 or even $4 on the earning date. What XERS really needs is that we need a new CEO and management team who can aggressively turn things around 🥲🥲

ForTGTX

@ForTGTX ive taken your bet.  nibbled nearly every day since the cort issues.  my reason is that recorlev is a differentiated product than corts product.  all the money spent on new sales for recorlev are taking root and i expect them to say they are spending even more money on more sales people.

David Evans

 ive taken your bet.  nibbled nearly every day since the cort issues.  my reason is that recorlev is a differentiated product than corts product.  all the money spent on new sales for recorlev are taking root and i expect them to say they are spending even more money on more sales people.

brian duelfer

@ForTGTX I&#39;ve said for several years now that mgmt. has been very good at getting drugs through and approved by FDA, and all credit to them for that, but it has not been at all good at creating shareholder value.  
Yes, SP is up nicely since the lows but still considerably lower than it had been before approvals and IMO does not reflect true company value by a long shot.  
And what the IR person has been doing still remains a mystery to me.  
I&#39;ve also said for quite a long time that yes, XERS needs a new mgmt. team with the experience and contacts needed to aggressively market the drugs and to bring greater visibility and attention to institutional shareholders who can significantly influence the share price. 
All to no avail as best I can determine. It&#39;s been a long 5 years and without some encouraging news along with a more visible, aggressive marketing program, the company sp will continue to lag. We&#39;ll see if Shannon can begin to turn things around with the next er report.

PSR Development

Alan

 I've said for several years now that mgmt. has been very good at getting drugs through and approved by FDA, and all credit to them for that, but it has not been at all good at creating shareholder value.  
Yes, SP is up nicely since the lows but still considerably lower than it had been before approvals and IMO does not reflect true company value by a long shot.  
And what the IR person has been doing still remains a mystery to me.  
I've also said for quite a long time that yes, XERS needs a new mgmt. team with the experience and contacts needed to aggressively market the drugs and to bring greater visibility and attention to institutional shareholders who can significantly influence the share price. 
All to no avail as best I can determine. It's been a long 5 years and without some encouraging news along with a more visible, aggressive marketing program, the company sp will continue to lag. We'll see if Shannon can begin to turn things around with the next er report.

@mcube1820 Yes. Just take a look at what IBRX has done over the last 5-6 months.  It is absolutely nothing but amazing. The current CEO of XERS does not know how to lead a great company like XERS and does not care about its share holders’ value. The CEO should be fired asap 🥲

 Yes. Just take a look at what IBRX has done over the last 5-6 months.  It is absolutely nothing but amazing. The current CEO of XERS does not know how to lead a great company like XERS and does not care about its share holders’ value. The CEO should be fired asap 🥲

@ForTGTX  it’s nice to see it not running up into earnings for once. Generally it runs to earnings and then sells off, so this pattern might set up better for a sustained uptrend from here. I’d put more of my money on that then it going to $4 that is an absolute joke

Insert Name Here

cheetohottaki

VitalBull

StockTwits for iOS

  it’s nice to see it not running up into earnings for once. Generally it runs to earnings and then sells off, so this pattern might set up better for a sustained uptrend from here. I’d put more of my money on that then it going to $4 that is an absolute joke

Flipper

@ForTGTX Sure,  4 or 5, another genius on the board.

StockTwits For Android 

 Sure,  4 or 5, another genius on the board.

G Asgard

@Flipperthedolphin  The absolute joke might actually become a reality because anything can happen to a small bio company. If some institutional investors are not happy about the new revenue guidance, they will dump this shit right off the bat. Hope I’m wrong on that, though😢

  The absolute joke might actually become a reality because anything can happen to a small bio company. If some institutional investors are not happy about the new revenue guidance, they will dump this shit right off the bat. Hope I’m wrong on that, though😢

@GuiltyAsCharged  The CEO of XERS should be fired, Bro

@ForTGTX all small bios have taken a hit since Q4 with the wall of worry In Q1. Its. anew year and I think they will have a good call and move Into 7-8 range, It Is down 35% from end of year ($6.5). This Is a good company, blockbuster drug (cortisol) with competitors failing recently. They will do well In 2026, market Is challenging most companies currently. They could get acquired If It drops to 5 they would be a  steal at that price. This will be a major acquisition year for good small bios BP Is hurting for revenue

 all small bios have taken a hit since Q4 with the wall of worry In Q1. Its. anew year and I think they will have a good call and move Into 7-8 range, It Is down 35% from end of year ($6.5). This Is a good company, blockbuster drug (cortisol) with competitors failing recently. They will do well In 2026, market Is challenging most companies currently. They could get acquired If It drops to 5 they would be a  steal at that price. This will be a major acquisition year for good small bios BP Is hurting for revenue